Antinuclear Antibody Test Market Size & Share, by Product (Assay Kits, Reagent kits, Software & Services); Disease (Scleroderma, Rheumatoid Arthritis, Systemic Lupus Erythematosus); Technology (Immunofluorescence, Multiplex Assay, ELISA); End-user (Hospitals, Clinical, Physician Laboratories) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4133
  • Published Date: Mar 10, 2023
  • Report Format: PDF, PPT

Companies Dominating the Antinuclear Antibody Test Landscape

    • F. Hoffmann-La Roche Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • ERBA Diagnostics, Inc.
    • Zeus Scientific Inc.
    • Trinity Biotech plc
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • Immuno Concepts Inc.
    • Euroimmun Medizinische Labordiagnostika AG
    • Antibodies Incorporated
    • Becton, Dickinson and Company 

Browse Key Market Insights with Data Illustration:


In The News

  • F. Hoffmann-La Roche Ltd received approval from the Food and Drug Administration (FDA) for its Evrysdi, a prescription medicine, to treat spinal muscular atrophy (SMA) in babies under two months of age.

  • The Food and Drug Administration (FDA) provided the clearance for the utilization of dIFine, a digital immunofluorescence system developed by Zeus Scientific Inc.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4133
  • Published Date: Mar 10, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising prevalence of autoimmune diseases and the growing population across the globe are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 13% over the forecast period, i.e., 2023-2035.

Lack of skilled professionals and errors during the diagnosis process is estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are F. Hoffmann-La Roche Ltd, ERBA Diagnostics, Inc., Zeus Scientific Inc., Trinity Biotech plc, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Immuno Concepts Inc, and Becton, Dickinson and Company.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, disease, technology, end user, and by region.

The ELISA segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying